Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia

NCT01644474 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Alirocumab
DRUG: Ezetimibe
DRUG: Placebo (for Alirocumab)
DRUG: Placebo (for Ezetimibe)

Sponsor

Sanofi

Collaborators

[object Object]